Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
PTP4A1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
SPTSSA - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
CD24 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors
SNX6 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
LAMP2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
C4orf32 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
USP32 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
ARL6IP6 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
NUP160 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
ATF1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
INHBC - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
CNOT8 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
TRAM1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
ACVR1C - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
CLIP1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
NPTN - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
RUFY3 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
DBR1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
TMOD3 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
DHODH - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on